Literature DB >> 28257172

Prescribed Benzodiazepines and Suicide Risk: A Review of the Literature.

Tyler J Dodds1,2.   

Abstract

OBJECTIVE: To evaluate whether prescribed benzodiazepines affect one's risk of suicide. DATA SOURCES: A PubMed search of English-language publications from database inception until October 11, 2016, was conducted using the terms benzodiazepine and suicide. References and related articles were also searched to yield additional publications. STUDY SELECTION/DATA EXTRACTION: Studies were included if they addressed the relationship between suicidal behavior and the prescribed use of either specific benzodiazepines or benzodiazepines as a class. A total of 17 studies were included in this review.
RESULTS: The majority of studies found that benzodiazepines were associated with increased suicide risk. This finding was consistent across various populations and different types of research, including a placebo-controlled crossover trial, a laboratory model of suicidal behavior, case-control studies regarding completed suicides on inpatient units, and large naturalistic studies.
CONCLUSIONS: Benzodiazepines appear to cause an overall increase in the risk of attempting or completing suicide. Possible mechanisms of prosuicidal effects may include increases in impulsivity or aggression, rebound or withdrawal symptoms, and toxicity in overdose. © Copyright 2017 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28257172     DOI: 10.4088/PCC.16r02037

Source DB:  PubMed          Journal:  Prim Care Companion CNS Disord        ISSN: 2155-7780


  31 in total

1.  Association between suicide death and concordance with benzodiazepine treatment guidelines for anxiety and sleep disorders.

Authors:  Jennifer M Boggs; Richard C Lindrooth; Catherine Battaglia; Arne Beck; Debra P Ritzwoller; Brian K Ahmedani; Rebecca C Rossom; Frances L Lynch; Christine Y Lu; Beth E Waitzfelder; Ashli A Owen-Smith; Gregory E Simon; Heather D Anderson
Journal:  Gen Hosp Psychiatry       Date:  2019-11-17       Impact factor: 3.238

2.  Concurrent use of benzodiazepines, antidepressants, and opioid analgesics with zolpidem and risk for suicide: a case-control and case-crossover study.

Authors:  Hi Gin Sung; Junquing Li; Jin Hyun Nam; Dae Yeon Won; BongKyoo Choi; Ju-Young Shin
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-04-29       Impact factor: 4.328

3.  Benzodiazepines Safe in Chronic Obstructive Pulmonary Disease? Don't Hold Your Breath.

Authors:  Abigail L Koch; Laura M Paulin
Journal:  Ann Am Thorac Soc       Date:  2019-01

Review 4.  Pharmacological interventions for self-harm in adults.

Authors:  Katrina G Witt; Sarah E Hetrick; Gowri Rajaram; Philip Hazell; Tatiana L Taylor Salisbury; Ellen Townsend; Keith Hawton
Journal:  Cochrane Database Syst Rev       Date:  2021-01-10

5.  Benzodiazepine consumption in Brazil: considerations regarding a population-specific scenario.

Authors:  Vinícius Dokkedal-Silva; José C F Galduróz; Sergio Tufik; Monica L Andersen
Journal:  Braz J Psychiatry       Date:  2020-04-03       Impact factor: 2.697

6.  Risks of Benzodiazepines in Chronic Obstructive Pulmonary Disease with Comorbid Posttraumatic Stress Disorder.

Authors:  Lucas M Donovan; Carol A Malte; Laura J Spece; Matthew F Griffith; Laura C Feemster; Ruth A Engelberg; David H Au; Eric J Hawkins
Journal:  Ann Am Thorac Soc       Date:  2019-01

7.  Real-world Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder.

Authors:  Markku Lähteenvuo; Antti Tanskanen; Heidi Taipale; Fabian Hoti; Pia Vattulainen; Eduard Vieta; Jari Tiihonen
Journal:  JAMA Psychiatry       Date:  2018-04-01       Impact factor: 21.596

Review 8.  On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review.

Authors:  Richard J Zeifman; Nikhita Singhal; Leah Breslow; Cory R Weissman
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-11

9.  Serum 3-Hydroxybutyrate in Patients with Psychogenic Somatoform Symptoms May Be a Predictor of the Effectiveness of Sertraline and Venlafaxine.

Authors:  Norihiro Saito; Masamichi Itoga; Satoko Minakawa; Hiroyuki Kayaba
Journal:  Int J Gen Med       Date:  2021-05-10

10.  Factors associated with opioid overdose during medication-assisted treatment: How can we identify individuals at risk?

Authors:  Vivian Y O Au; Tea Rosic; Nitika Sanger; Alannah Hillmer; Caroul Chawar; Andrew Worster; David C Marsh; Lehana Thabane; Zainab Samaan
Journal:  Harm Reduct J       Date:  2021-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.